Cancer Biology and Molecular Biology

Basic terms used in genomic medicine

Sample handling

Central Review of Pathology Specimens

Next-generation sequencing principles and analysis files

Procedures and Interpretation of Next Generation Sequencing Results

Medical genetics and Hereditary tumors

Communication with Patients when Providing Genomic Testing Results

Administrative perspectives and staffing to conduct genomic medicine

Second opinion and Management

Basic knowledge of ISO 15189 - Quality Management System -

ISO 15189 accreditation program for molecular-genetic laboratories

Management system specific to molecular-genetic tests

Technical requirements specific to molecular-genetic tests (Part-1)

Technical requirements specific to molecular-genetic tests (Part-2)

Educational Curriculum, Qualification, and Career Development of Laboratory Professionals in Molecular Biology

ISO 15189 Clinical Laboratory Accreditation - Accreditation of gene-related testing -

Basic Knowledge and Practical Consideration of Phase I Trials in Oncology

Responsibilities of principal investigators and important personnel in Phase I clinical trial team

Evaluation of non-clinical trials related to Phase 1 trials

Current trends in Phase I trials

Minimum statistical knowledge required for clinical trials on cancer - Part 1 of 2

Minimum statistical knowledge required for clinical trials on cancer - Part 2 of 2

Designs for clinical trials on cancer - Part 1 of 2

Designs for clinical trials on cancer - Part 2 of 2

Response evaluation and adverse events - Part 1 of 2

Response evaluation and adverse events - Part 2 of 2

Opening Remarks (Hitoshi Nakagama)

Message from guest_1 (Keizo Takemi)

Message from guest_2 (Nutthapong Wongwiwat)

Message from guest_3 (Kazuya Nashida)

Overview of the ATLAS project (Kenichi Nakamura)

About Asian Partnerships Office in Bangkok (Tomohiro Matsuda)

Master Key Asia and Int'l Res & Development (Hitomi Okuma)

Acceleration of TR in Asia (Kazuki Sudo)

How to build up the network and expectations for ATLAS project (Akhmal Yusof)

How to build up the network and expectations for ATLAS project (Marcelo Imasa)

How to build up the network and expectations for ATLAS project (Ekaphop Sirachainan)

How to build up the network and expectations for ATLAS project (Pham Tuan Anh)

How to build up the network and expectations for ATLAS project (Elys Dariatmo Herik)

Message from PMDA (Yasuhiro Fujiwara)

Current status of ASIA One (Noboru Yamamoto)

Phase 1 trials in Malaysia (Voon Pei Jye)

Phase 1 trials in Thailand (Kulkanya Chokephaibulkit)

Session3：Q＆A

Collaborative researches in Asia by NCC Research institute (Tatsuhiro Shibata)

International Research Collaboration for cancer prevention in Asia (Manami Inoue)

National platform of cancer genomic medicine in Japan (Hiroyuki Mano)

Establishment of infrastructure for genomic medicine (Tatsunori Shimoi)

Genomic medicine in Thailand (Virote Sriuranpong)

Session5：Q＆A

Closing Remarks (Kazuaki Shimada)

Opening remarks

Phase I and FIH -From NCCH experience-

First in Human (FIH) trials The role of the clinical trial office

First in Human (FIH) trials The role of the CRC

[Part 1] Opening Remarks and Introduction of ATLAS: Head and Neck Cancer

[Part 2] Immunotherapy and novel approaches in HNSCC (head and neck squamous cell carcinoma): Head and Neck Cancer

[Part 3] From global to local: Malaysia's experience in clinical trials in head and neck cancer Facilitator + Discussion: Head and Neck Cancer

[Part 1] Opening Remarks and Introduction of ATLAS: Lung Cancer

[Part 2] Recent advance in treatment for early-stage non-small cell lung cancer: Lung Cancer

[Part 3] Lung Cancer screening program utilizing CT scans in South Korea: Lung Cancer

[Part 4]Discussion: Lung Cancer

[Part 1] Opening Remarks and Introduction of ATLAS: Malignancy in People Living with HIV

[Part 2] HIV associated malignancies: Malignancy in People Living with HIV

[Part 3] HIV and Malignancies: Challenges in Diagnosis and Management: Malignancy in People Living with HIV

[Part 4] Discussion : Malignancy in People Living with HIV

[Part 1] Opening Remarks and Introduction of ATLAS: Melanoma

[Part 2] Systemic treatment trajectories of malignant melanoma and future outlook: Melanoma

[Part 3] Currently systemic therapies for melanoma in Viet Nam: Melanoma

[Part 4] Discussion : Melanoma

[Part 1] Opening Remarks and Introduction of ATLAS: Radiation Oncology

[Part 2] MR-Linac Experience from Siriraj Hospital: Radiation Oncology

[Part 3] BNCT for Head and Neck: Radiation Oncology

[Part 4] Discussion: Radiation Oncology

Endoscopy| ATLAS Webinar Jan 2025

Cervical Cancer| ATLAS Webinar Feb 2025

Sarcoma| ATLAS Webinar Mar 2025

Collaboration in cancer research across different Asian countries| ATLAS Webinar Apr 2025

Academia-Regulatory Collaboration for Asian Therapeutic Development| ATLAS Webinar May 2025

Locally Advanced Rectal Cancer| ATLAS Webinar Jul 2025

Liquid Biopsy and Emerging Biomarkers| ATLAS Webinar Aug 2025

Cancer Registration and Epidemiology in Asia| ATLAS Webinar Sep 2025

Perioperative Immune Therapy in Gastric Cancer| ATLAS Webinar Nov 2025

Particle Radiation Therapy| ATLAS Webinar Dec 2025